Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.8 |
mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |
mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0097 | 0.8 |
mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.8 |
mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.8 |
mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.8 |
mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | 0.0088 | 0.8 |